UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Position in Hawkins, Inc. $HWKN

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its position in Hawkins, Inc. (NASDAQ:HWKN) by 13.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 39,730 shares of the specialty chemicals company’s stock after selling 6,327 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Hawkins were worth $5,646,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HWKN. AQR Capital Management LLC grew its stake in Hawkins by 9.0% during the 1st quarter. AQR Capital Management LLC now owns 12,331 shares of the specialty chemicals company’s stock valued at $1,306,000 after purchasing an additional 1,017 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Hawkins by 4.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,499 shares of the specialty chemicals company’s stock worth $1,218,000 after purchasing an additional 494 shares during the period. Jane Street Group LLC lifted its holdings in shares of Hawkins by 83.2% during the first quarter. Jane Street Group LLC now owns 38,416 shares of the specialty chemicals company’s stock worth $4,069,000 after purchasing an additional 17,447 shares during the period. Invesco Ltd. boosted its position in Hawkins by 50.3% in the second quarter. Invesco Ltd. now owns 282,349 shares of the specialty chemicals company’s stock valued at $40,122,000 after buying an additional 94,503 shares during the last quarter. Finally, Amundi boosted its position in Hawkins by 131.2% in the second quarter. Amundi now owns 5,223 shares of the specialty chemicals company’s stock valued at $787,000 after buying an additional 2,964 shares during the last quarter. Hedge funds and other institutional investors own 69.71% of the company’s stock.

Insider Activity at Hawkins

In other news, VP Douglas Lange bought 910 shares of the firm’s stock in a transaction that occurred on Tuesday, August 25th. The stock was purchased at an average cost of $118.75 per share, for a total transaction of $108,062.50. Following the purchase, the vice president directly owned 28,169 shares in the company, valued at approximately $3,345,068.75. This trade represents a 3.34% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Jeffrey P. Oldenkamp purchased 1,290 shares of the stock in a transaction that occurred on Thursday, August 27th. The shares were purchased at an average cost of $119.00 per share, for a total transaction of $153,510.00. Following the completion of the acquisition, the chief financial officer directly owned 104,223 shares of the company’s stock, valued at $12,402,537. This represents a 1.25% increase in their position. The SEC filing for this purchase provides additional information. 3.70% of the stock is owned by insiders.

Hawkins Stock Down 1.6%

Shares of HWKN opened at $127.00 on Wednesday. The company has a market capitalization of $2.65 billion, a price-to-earnings ratio of 32.90, a PEG ratio of 2.63 and a beta of 0.77. Hawkins, Inc. has a 52 week low of $116.04 and a 52 week high of $186.15. The stock’s 50-day moving average price is $131.78 and its 200-day moving average price is $146.29. The company has a quick ratio of 1.54, a current ratio of 2.27 and a debt-to-equity ratio of 0.45.

Hawkins (NASDAQ:HWKN) last announced its quarterly earnings results on Wednesday, July 29th. The specialty chemicals company reported $1.35 earnings per share for the quarter, missing the consensus estimate of $1.39 by ($0.04). Hawkins had a net margin of 7.29% and a return on equity of 15.42%. The company had revenue of $315.68 million for the quarter, compared to analysts’ expectations of $313.42 million. On average, sell-side analysts predict that Hawkins, Inc. will post 4.1 EPS for the current year.

Hawkins Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 28th. Stockholders of record on Friday, August 14th were issued a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, August 14th. Hawkins’s payout ratio is 20.73%.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on HWKN. Barclays set a $142.00 price target on shares of Hawkins and gave the stock an “equal weight” rating in a report on Friday, July 31st. Weiss Ratings downgraded shares of Hawkins from a “hold (c+)” rating to a “hold (c)” rating in a report on Thursday, August 27th. BWS Financial reiterated a “buy” rating and issued a $200.00 price objective on shares of Hawkins in a research note on Monday, August 3rd. Finally, Zacks Research cut shares of Hawkins from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 4th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $171.00.

Hawkins Company Profile

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.